Skip to content

Magnetoencephalography by Optical Pumping Magnetometer

Magnetoencephalography by Optical Pumping Magnetometer

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05835817
Acronym
MEG OPM
Enrollment
70
Registered
2023-04-28
Start date
2023-04-11
Completion date
2026-04-30
Last updated
2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Magnetoencephalography, Optical Pump Magnetometer, Neonate, Premature

Keywords

Magnetoencephalography, optical pump magnetometer, neonate, Premature

Brief summary

MagnetoEncephaloGraphy (MEG) is a method of recording brain activity with high temporal resolution and good spatial resolution, compared to current recording techniques such as ElectroEncephaloGraphy (EEG). The main limitation of MEG is its cost due to the sensors used, the Super Quantum Interference Devices (SQUID). These require a complex infrastructure from an instrumentation point of view to operate, requiring liquid helium, most often at a loss, at increasing cost. Optical Pumping Magnetometers (OPM) type sensors represent a promising alternative to SQUIDs sensors, especially since they do not require helium cooling. The purpose of this project is to Identify biomarkers in Magnetoencephalography of normal brain development in healthy adults, premature and term newborns from a priori obtained by the classical technique of High Resolution EEG performed.

Interventions

40 minutes of Magnetoencephalography with Optical Pump Magnetometer

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
1 Days to No maximum
Healthy volunteers
Yes

Inclusion criteria

* For healthy adult volunteers * Age between 18 and 65 * No pathology, no treatment * No toxicant intake * For term newborns * Child between 38 and 42 weeks gestational age on the day of registration * No pathology, no treatment * For children born prematurely * Child between 28 and 36 weeks gestational age on the day of registration * No pathology, no treatment apart from routine care related to prematurity * For pregnant women * Pregnant with between 28 to 40 weeks gestational age on the day of registration * No pathology, no treatment

Exclusion criteria

* Subject and Patients not compatible MEG. Wearers of prosthesis or pacemaker likely to generate artefacts interfering with the measurement. There is no danger to the subject, but the measurement itself may be impossible. * Patients who cannot stand to stand still for a few minutes. * Newborn on ventilatory assistance or infusion * Newborn baby not meeting the age criteria

Design outcomes

Primary

MeasureTime frameDescription
Signal to noise ratio of the MEG OPM1 daySignal to noise ratio of the MEG OPM is in dB
Signal to noise ratio of HR EEG1 daySignal to noise ratio of HR EEG is in dB
Number of dB between Signal to noise ratio of the MEG OPM and Signal to noise ratio of HR EEG1 day

Countries

France

Contacts

Primary ContactFabrice Wallois, Pr
wallois.fabrice@chu-amiens.fr03 22 08 80 51

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026